Captor Therapeutics Spolka Akcyjna (WSE:CTX)

WSE:CTX Revenue

Captor Therapeutics Spolka Akcyjna had revenue of 1.63M PLN in the quarter ending June 30, 2026, a decrease of -18.71%. This brings the company's revenue in the last twelve months to 2.01M, down -81.93% year-over-year. In the year 2025, Captor Therapeutics Spolka Akcyjna had annual revenue of 4.66M, down -70.55%. That makes Captor Therapeutics Spolka Akcyjna the 44,504th largest company in the world by revenue and 504th in Poland.

• Revenue (ttm): 2.01M
• Revenue Growth: -81.93%
• P/S Ratio: 180.53
• Revenue / Employee: n/a
• Employees: 82
• Market Cap: 362.14M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	4.66M	-11.17M	-70.55%
Dec 31, 2024	15.83M	2.62M	19.88%
Dec 31, 2023	13.20M	4.04M	44.15%
Dec 31, 2022	9.16M	5.17M	129.75%
Dec 31, 2021	3.99M	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-
Dec 31, 2018	16.00K	-458.00K	-96.62%
Dec 31, 2017	474.00K	-	-

Data Source: Fiscal.ai Last updated: Sep 15, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 17, 2026

Data Sources Report a data error